Control of Virus-\associated Hemophagocytic Syndrome by Peroxisome Proliferator Activated Receptor Agonists in a Rabbit Model

por Hsieh, W.C., Lan, B.S., Su, I.J.
Publicado 2008

OL-043 Mechanism and therapeutic efficacy of peroxisome proliferator activated receptor agonist for virus-associated hemophagocytic syndrome

por Chen, Y.L., Hsieh, W.C., Lan, B.S., Su, I.J.
Publicado 2008

Clinicopathological features of bladder cancer associated with chronic exposure to arsenic.

por Chow, N. H., Guo, Y. L., Lin, J. S., Su, J. H., Tzai, T. S., Guo, H. R., Su, I. J.
Publicado 1997

Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity

por Lin, Y S, Lin, C F, Fang, Y T, Kuo, Y M, Liao, P C, Yeh, T M, Hwa, K Y, Shieh, C C K, Yen, J H, Wang, H J, Su, I J, Lei, H Y
Publicado 2005

Using an integrated infection control strategy during outbreak control to minimize nosocomial infection of severe acute respiratory syndrome among healthcare workers

por Yen, M.-Y., Lin, Y.E., Su, I.-J., Huang, F.-Y., Huang, F.-Y., Ho, M.-S., Chang, S.-C., Tan, K.-H., Chen, K.-T., Chang, H., Liu, Y.-C., Loh, C.-H., Wang, L.-S., Lee, C.-H
Publicado 2006